TriSalus Life Sciences, Inc.
- TLSI
- NASDAQ
- Medical devices
- Immunotherapy
- Medical Devices (Infusion)
$3.63
Today −6.92%Quote Oct 16, 2026, 08:00 PM UTC
−25.92%over the last month
Max drawdown −28.8%From 1-month high −28.8%3 months −15.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$223.5M
Quote Oct 16
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$11.00
+203.0% from here
Floor
$3.61
0.4% below price
Where the price sits
4 analysts
Analyst range, low to high
$8.00$12.00
- Price $3.63
- Resistance $3.82
- Consensus $11.00
The price is just above its floor. Analysts' average target sits about 203% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about TLSIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Medical devices
Employees
102